Truist Securities Maintains Hold on Inspire Medical Systems, Raises Price Target to $78
Barclays Initiates Coverage of Inspire Medical Systems at Underweight
Barclays Initiates Coverage On Inspire Medical Systems with Underweight Rating, Announces Price Target of $65
Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026
How Investors Are Reacting To Inspire Medical Systems (INSP) Securing Category I CPT Codes For Inspire V
Medical Devices & Supplies - Specialty Stocks Q2 Earnings Review: Inspire Medical Systems (NYSE:INSP) Shines
Inspire Medical (INSP): How Much Optimism Is Baked Into This Medtech Stock?
Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel
Inspire Medical Systems Receives American Medical Association CPT Editorial Panel Approval To Establish New Set Of Current Procedural Terminology Codes
RBC Capital Maintains Sector Perform on Inspire Medical Systems, Raises Price Target to $75
Inspire Medical Systems (INSP) Stock Could Be A Bargain On Cash Flow
Inspire Medical Systems (INSP) Faces A Rebound Question As Fair Value Stays In Focus
Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Raises Price Target to $97
Inspire Medical Systems (INSP) Stock Could Be 14% Undervalued On Cash Flow
Why Inspire Medical Systems (INSP) Stock Is Up Today
Stifel Maintains Buy on Inspire Medical Systems, Raises Price Target to $80
Inspire Medical Systems (INSP): Buy, Sell, or Hold Post Q2 Earnings?
Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
Inspire Medical Systems (INSP) Stock May Be Cheap After A 74% Fall
5 Insightful Analyst Questions From Inspire Medical Systems’s Q2 Earnings Call
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.